Stock listing
Nippon Chemiphar Co., Ltd.
Selected listing: 4539 · TSE · JPY · JP
Nippon Chemiphar Co., Ltd. (Tokyo:4539), Health Technology. Latest release Jan 15, 2026: Nippon Chemiphar : Patient Enrollment Started for Phase IIa Clinical…
- Ticker
- Tokyo:4539
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- Tokyo
- Currency
- JPY
About Nippon Chemiphar Co., Ltd.
Nippon Chemiphar Co., Ltd. is a public company listed on the Japanese stock market under the ticker 4539. Nippon Chemiphar is involved in the pharmaceutical industry, focusing on the development and manufacturing of various healthcare products.
Latest news from Nippon Chemiphar Co., Ltd.
Nippon Chemiphar : Patient Enrollment Started for Phase IIa Clinical Trial on δ-Opioid Receptor Agonist NC-2800 in Patients with Depression.
January 15, 2026
Nippon Chemiphar : Notice Concerning Recording of Gain on Sales of Investment Securities (Extraordinary Income)
June 4, 2025
Nippon Chemiphar : Notice of the 93rd Ordinary General Meeting of Shareholders.
May 26, 2025
Nippon Chemiphar : Notice of the 91st Ordinary General Meeting of Shareholders.
May 29, 2023
Research Nippon Chemiphar Co., Ltd.
Nippon Chemiphar Co., Ltd. company profile
View the public company page for Nippon Chemiphar Co., Ltd. on 6ix.
Nippon Chemiphar Co., Ltd. news
Read company news and market updates connected to Nippon Chemiphar Co., Ltd..
Nippon Chemiphar Co., Ltd. investor events
Find investor webinars, events, and replay context for Nippon Chemiphar Co., Ltd..